STING1 and neoplasm: cGAS, a known sensor of foreign DNA in pathogens and tumors, and known to activate type I IFNs by STING, has recently attracted attention as a good target for cancer therapy.7 The present study reveals a new aspect of ERIs, which are microtubule polymerization inhibitors, but their mechanism for anti-tumor activity is not fully understood.